Conciliación de la medicación al ingreso en paciente crónico pediátrico: estudio multicéntrico
- Margarita Cuervas-Mons Vendrell
- Dolores Pilar Iturgoyen Fuentes
- Joëlle Arrojo Suárez
- Inés Jimenez Lozano
- Cecilia Martínez Fernandez-Llamazares
- Angela Tristancho-Perez
- Luca Yunquera Romero
- Cristina Martínez Roca
- Cristina Otero Villalustre
- Ana García Robles
- Beatriz Garrido Corro
- Belén Rodríguez Marrodán
ISSN: 1695-4033, 1696-4608
Ano de publicación: 2023
Volume: 99
Número: 6
Páxinas: 376-384
Tipo: Artigo
Outras publicacións en: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )
Resumo
Introduction Medication reconciliation (MR) is one of the main strategies used to reduce medication errors in care transitions. In Spain, several guidelines have been published with recommendations for the implementation and development of MR processes aimed at the adult population, and not applicable to paediatric patients. In 2018, a study was carried out that allowed the subsequent publication of a document establishing criteria for the selection of paediatric patients in whom CM should be prioritised. Objectives To describe the characteristics of the paediatric patients most likely to be subject to reconciliation errors (REs) to confirm whether the results of a previous study could be extrapolated. Methodology Prospective, multicentre study in paediatric inpatients. We analysed the REs detected in the MR at the time of admission. We obtained the best possible medication history of the patient using different sources of information, subsequently confirmed through an interview with the patient/caregiver. Results 1043 discrepancies were detected, of which 544 were categorised as REs, affecting 317 patients (43%). Omission of a drug was the most common error (51%). Most REs involved drugs in groups A (31%), N (23%) and R (11%) of the ATC classification. Polypharmacy and oncological/haematological disease were the risk factors that exhibited a statistically significant association with the occurrence of REs. Conclusions The findings of this study allow the prioritisation of MR in a specific group of paediatric patients, contributing to improve the efficiency of the process. Oncological/haematological disease and polypharmacy were confirmed as the main risk factors for the occurrence of REs in the paediatric population.